In this context, the prostate-specific antigen (PSA) test, as well as the tumor, node, metastasis (TNM) classification and the Gleason score in prostate biopsies, are routinely used for predicting the prognosis and informing treatment decisions [2]. Here, KLK3 is linked to neoplasm.